Employers added 139,000 jobs last month, continuing a steady run of hiring despite policy turmoil. The unemployment rate was ...

The Federal Circuit recently considered the scope of a permanent injunction that prohibited a drug manufacturer from ...

A new FDA application for vepdegestrant offers hope for advanced breast cancer patients with ESR1 mutations, showcasing ...

Fecal microbiota transplants (FMT) have been touted as a potential treatment for a variety of conditions, from inflammatory ...

Vepdegestrant showed a benefit for patients with ER-positive, HER2-negative, ESR1-mutated breast cancer who had previously received endocrine-based therapy.

The development of innovative pharmaceuticals targeting refractory mental health conditions has stagnated for decades. In recent years, ...

It was the world’s largest police sting that rocked the nation’s criminal underground and saw 108 South Australians arrested ...

Tylah Tully chats with Recce Pharmaceuticals (ASX:RCE) managing director and CEO James Graham about the company's recent ...

Kura Oncology and Kyowa Kirin submitted data from the KOMET-001 trial, which the agency will review and decide whether to approve the drug by Nov. 30.

Interim results from a small group of children in a Phase I/II trial are essentially in line with that of Elevidys, according ...

As the weather heats up and Americans head outside, applying and reapplying sunscreen could help protect from skin cancer ...

Kerassentials is a meticulously formulated toenail infection treatment solution that targets more problematic issues, such as ...